Mechanisms of Action Ozempic : Mimics GLP-1 to regulate insulin and suppress appetite
SNAI1-activated long non-coding RNA LINC01711 promotes hepatic fibrosis cell proliferation and migration by regulating XYLT1
Since then, others have been made, including: Liraglutide (Victoza for diabetes, Saxenda for weight loss) Dulaglutide (Trulicity), Lixisenatide (Adlyxin) Semaglutide (Ozempic, Wegovy, and Rybelsus, which is a tablet) Tirzepatide (Mounjaro and Zepbound) works on two gut hormones, not just GLP1
BPC-157 is unusually stable in human gastric juice for a peptide, which is why oral and capsule formats appear in research planning, especially for gut models
Higher overall GI rate than semaglutide alone, reflecting dual mechanism